Award reduced in Texas Vioxx case

Share this article:
A judge in a Texas lawsuit over Merck's Vioxx today reduced a $32 million jury award to $7.75 million, citing Texas' recently enacted caps on punitive damages, according to a story appearing on The Wall Street Journal's Web site.

The state jury in April found Merck liable for the death of Leonel Garza, a 71-year-old man who had a fatal heart attack within a month of taking the withdrawn painkiller. Merck was ordered to pay Garza's family $7 million in non-economic compensatory damages and $25 million in punitive damages.

But Judge Alex Gabert ordered the punitive damage reduced as required by state law. The law caps punitive damages at twice the amount of economic damages – lost pay—and up to $750,000 on top of non-economic damages. Because Garza was retired, the jury awarded no economic damages, so Merck was ordered to pay the most the family could receive under state law.
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.